Published in Schizophr Res on April 17, 2011
Gone to Pot - A Review of the Association between Cannabis and Psychosis. Front Psychiatry (2014) 1.14
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential. Neurotherapeutics (2015) 0.91
Impact of Cannabis Use on the Development of Psychotic Disorders. Curr Addict Rep (2014) 0.85
Psychotic disorders in children and adolescents: a primer on contemporary evaluation and management. Prim Care Companion CNS Disord (2014) 0.76
Cannabis use and cognitive function in first episode psychosis: differential effect of heavy use. Psychopharmacology (Berl) (2015) 0.76
Cannabis and development of dual diagnoses: A literature review. Am J Drug Alcohol Abuse (2016) 0.75
Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry (2005) 5.17
Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet (2003) 4.91
The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry (2013) 4.16
Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry (2010) 3.88
Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophr Res (2003) 3.86
Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry (2010) 3.82
Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch Gen Psychiatry (2006) 3.62
Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res (2004) 3.55
Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry (2008) 2.89
Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry (2008) 2.86
Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry (2005) 2.62
Validation of "prodromal" criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res (2008) 2.45
Structural brain imaging evidence for multiple pathological processes at different stages of brain development in schizophrenia. Schizophr Bull (2005) 2.13
Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale. Aust N Z J Psychiatry (2012) 2.02
Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study. JAMA Psychiatry (2013) 2.02
Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophr Res (2009) 1.98
Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophr Bull (2009) 1.85
Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry (2005) 1.84
Australian mental health reform: time for real outcomes. Med J Aust (2005) 1.81
Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci U S A (2007) 1.80
Vocational intervention in first-episode psychosis: individual placement and support v. treatment as usual. Br J Psychiatry (2008) 1.74
N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial. Biol Psychiatry (2008) 1.73
PACE: a specialised service for young people at risk of psychotic disorders. Med J Aust (2007) 1.72
Pituitary volume in psychosis. Br J Psychiatry (2004) 1.70
Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Arch Gen Psychiatry (2009) 1.70
Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry (2006) 1.69
Impairment of olfactory identification ability in individuals at ultra-high risk for psychosis who later develop schizophrenia. Am J Psychiatry (2003) 1.67
A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. J Med Genet (2012) 1.63
Stress, the hippocampus and the hypothalamic-pituitary-adrenal axis: implications for the development of psychotic disorders. Aust N Z J Psychiatry (2006) 1.62
Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology (2007) 1.61
The significance of at-risk symptoms for psychosis in children and adolescents. Can J Psychiatry (2013) 1.60
Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial. Addiction (2011) 1.59
Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry (2009) 1.56
Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull (2006) 1.54
The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe. World Psychiatry (2005) 1.52
Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine. Int J Neuropsychopharmacol (2005) 1.50
Intervention in at-risk states for developing psychosis. Eur Arch Psychiatry Clin Neurosci (2010) 1.50
Psychological needs of adolescents in the early phase of bipolar disorder: implications for early intervention. Early Interv Psychiatry (2011) 1.46
Pilot study evaluating the effect of massage therapy on stress, anxiety and aggression in a young adult psychiatric inpatient unit. Aust N Z J Psychiatry (2008) 1.46
Childhood trauma and psychotic disorders: a systematic, critical review of the evidence. Schizophr Bull (2007) 1.45
Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment. J Clin Psychiatry (2015) 1.40
Guidelines for youth depression: time to incorporate new perspectives. Med J Aust (2010) 1.39
Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res (2006) 1.38
Prediction of psychosis by mismatch negativity. Biol Psychiatry (2010) 1.38
Funding for mental health research: the gap remains. Med J Aust (2011) 1.38
Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis. Schizophr Res (2007) 1.38
Psychotic-like experiences in nonpsychotic help-seekers: associations with distress, depression, and disability. Schizophr Bull (2005) 1.38
Increased access to evidence-based primary mental health care: will the implementation match the rhetoric? Med J Aust (2007) 1.36
Progressive changes in the development toward schizophrenia: studies in subjects at increased symptomatic risk. Schizophr Bull (2008) 1.32
The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull (2010) 1.32
Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol Psychiatry (2008) 1.31
Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals. Schizophr Bull (2003) 1.30
Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry (2011) 1.30
Probably at-risk, but certainly ill--advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophr Res (2010) 1.26
Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry (2005) 1.24
Medium term follow-up of a randomized controlled trial of interventions for young people at ultra high risk of psychosis. Schizophr Res (2007) 1.23
Two-year stability of personality disorder in older adolescent outpatients. J Pers Disord (2004) 1.23
Recognition of depression and psychosis by young Australians and their beliefs about treatment. Med J Aust (2005) 1.23
Development and evaluation of a youth mental health community awareness campaign - The Compass Strategy. BMC Public Health (2006) 1.22
Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. J Clin Psychiatry (2007) 1.21
Non-reduction in hippocampal volume is associated with higher risk of psychosis. Schizophr Res (2002) 1.20
Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophr Res (2005) 1.20
Is diagnosis enough to guide interventions in mental health? Using case formulation in clinical practice. BMC Med (2012) 1.19
The initial prodrome to bipolar affective disorder: prospective case studies. J Affect Disord (2003) 1.18
The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord (2007) 1.17
Remission in schizophrenia: validity, frequency, predictors, and patients' perspective 5 years later. Dialogues Clin Neurosci (2010) 1.17
Influence of gender on mental health literacy in young Australians. Aust N Z J Psychiatry (2006) 1.17
Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol Psychiatry (2007) 1.17
The phenomenological critique and self-disturbance: implications for ultra-high risk ("prodrome") research. Schizophr Bull (2007) 1.16
Prediction and prevention of schizophrenia: what has been achieved and where to go next? World Psychiatry (2011) 1.15
Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial. Br J Psychiatry (2008) 1.14
Predictors of vocational recovery among young people with first-episode psychosis: findings from a randomized controlled trial. Psychiatr Rehabil J (2012) 1.14
Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Aust N Z J Psychiatry (2003) 1.14
Anatomic abnormalities of the anterior cingulate cortex before psychosis onset: an MRI study of ultra-high-risk individuals. Biol Psychiatry (2008) 1.14
Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry (2007) 1.14
Surface-based morphometry of the anterior cingulate cortex in first episode schizophrenia. Hum Brain Mapp (2008) 1.14
Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group. Aust N Z J Psychiatry (2002) 1.14
Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. J Clin Psychiatry (2010) 1.13
Family outcomes from a randomized control trial of relapse prevention therapy in first-episode psychosis. J Clin Psychiatry (2009) 1.13
Whither the attenuated psychosis syndrome? Schizophr Bull (2012) 1.12
Pharmacological treatment of primary negative symptoms in schizophrenia: a systematic review. Schizophr Res (2006) 1.11
Applying clinical staging to young people who present for mental health care. Early Interv Psychiatry (2012) 1.11
Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophrenia. Eur Arch Psychiatry Clin Neurosci (2009) 1.11
Pre-emptive intervention in psychosis: agnostic rather than diagnostic. Aust N Z J Psychiatry (2011) 1.10
Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia. J Clin Exp Neuropsychol (2006) 1.10
Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis. Schizophr Res (2009) 1.10
Disability in people clinically at high risk of psychosis. Br J Psychiatry (2010) 1.10
Internet-based interventions for psychosis: a sneak-peek into the future. Psychiatr Clin North Am (2012) 1.09
White matter volume changes in people who develop psychosis. Br J Psychiatry (2008) 1.09
Pre-treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophr Res (2007) 1.09